COMPANIESAPOGEE MEDICAL GROUP, DELAWARE, INC.
✓ Verified H1B Sponsor

APOGEE MEDICAL GROUP, DELAWARE, INC.

Dallas, TXEIN 462187372
TRUST SCORE
87.4
High Trust
12
FY2024 H1B Approvals
15
All-time Approvals
87.4
Trust Score / 100

TOP SPONSORED JOB CATEGORIES

Hospitalists

RECENT H1B FILINGS

JOB TITLELOCATIONWAGEDATE
HospitalistsDallas, TX$385,440Dec 2025
HospitalistsDallas, TX$314,367Nov 2025
HospitalistsDallas, TX$314,367Jul 2025
HospitalistsDallas, TX$314,367Jul 2025
HospitalistsDallas, TX$330,583Jul 2025
HospitalistsDallas, TX$314,367Jul 2025
HospitalistsDallas, TX$378,322Jul 2025
HospitalistsDallas, TX$314,367Jul 2025
HospitalistsDallas, TX$314,367Jul 2025
HospitalistsDallas, TX$378,322Jul 2025
HospitalistsDallas, TX$314,367Jun 2025
HospitalistsDallas, TX$314,367Jun 2025
HospitalistsDallas, TX$289,737Sep 2024
HospitalistsDallas, TX$289,737Aug 2024
HospitalistsDallas, TX$314,367Jul 2024

SHOWING 50 MOST RECENT · SOURCE: DOL LCA PUBLIC DATA FY2024 · EIN 462187372

FREQUENTLY ASKED QUESTIONS

Does APOGEE MEDICAL GROUP, DELAWARE, INC. sponsor H1B visas?

Yes. APOGEE MEDICAL GROUP, DELAWARE, INC. has an active H1B sponsorship history with 15 total approved LCA filings on record, including 12 approvals in FY2024. Data sourced from US Department of Labor public disclosure files.

How many H1B visas has APOGEE MEDICAL GROUP, DELAWARE, INC. sponsored?

According to DOL LCA data, APOGEE MEDICAL GROUP, DELAWARE, INC. has 15 all-time H1B approvals and 12 approvals in fiscal year 2024.

What types of roles does APOGEE MEDICAL GROUP, DELAWARE, INC. sponsor H1B for?

APOGEE MEDICAL GROUP, DELAWARE, INC. most commonly sponsors H1B visas for: Hospitalists. This is based on their DOL Labor Condition Application filing history.

Is APOGEE MEDICAL GROUP, DELAWARE, INC. a reliable H1B sponsor?

APOGEE MEDICAL GROUP, DELAWARE, INC. has a Trust Score of 87.4/100 on KEEL, calculated from total approval volume, recency of filings, and approval consistency based on DOL LCA data.

DATA SOURCE: US DEPT. OF LABOR · LCA PUBLIC DISCLOSURE FY2023–FY2024